flutamide and buserelin

flutamide has been researched along with buserelin in 53 studies

Research

Studies (53)

TimeframeStudies, this research(%)All Research%
pre-199017 (32.08)18.7374
1990's33 (62.26)18.2507
2000's2 (3.77)29.6817
2010's1 (1.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fleshner, NE; Trachtenberg, J1
Schmeller, N1
Armitage, TG; Cooper, EH; Denis, L; Newling, DW; Richards, BR; Robinson, MR; Smith, PH; Sylvester, R1
Bono, A; Carneiro de Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Robinson, M; Smith, P; Sylvester, R1
Baldelli, S; Cellerino, R; Menichetti, ET; Miseria, S; Murer, B; Torresi, U; Tummarello, D1
Fischer, M; Flamm, J; Höltl, W; Pflüger, H; Tomschi, W1
Altwein, JE; Boccardo, F; Haefliger, JM; Holdaway, IM; Jordaan, JP; Klippel, F; Lunglmayr, G; Tyrrell, CJ; Varenhorst, E1
Horlbeck, R; Jurincic, CD; Klippel, KF1
Andrade, JA; Oliveira, MG; Oliveira, PD; Pina, F; Pina-Cabral, JM1
Berná, L; Blanco, R; Carrió, I; Estorch, M; Germá, JR; Torres, G1
Denis, L2
Ayub, M; Levell, MJ1
Armitage, TG; Bono, A; Calais da Silva, F; Debruyne, F; Denis, L; Robinson, P; Smith, PH; Sylvester, R1
De Pauw, M; Denis, L; Newling, DW; Robinson, MR; Sylvester, R1
Christensen, I; Denis, L; Iversen, P; Suciu, S; Sylvester, R2
Bond, A; Carvalho, AP; De Pauw, M; Denis, L; Keuppens, F; Newling, D; Ongena, P; Smith, P; Sylvester, R; Vermeylen, K1
Christensen, MG; Friis, E; Hornbøl, P; Hvidt, V; Iversen, HG; Iversen, P; Klarskov, P; Krarup, T; Lund, F; Mogensen, P1
Schulze, H; Senge, T1
Bono, A; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Pinto de Carvalho, AP; Robinson, M; Smith, P; Sylvester, R1
D'Eramo, G; Di Silverio, F; Sciarra, F1
Hwang, YS; John, MJ; Krall, JM; McGowan, D; Perez, CA; Pilepich, MV1
Bono, A; De Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, D; Robinson, M; Smith, P; Sylvester, R1
Guidez, C1
Lunglmayr, G2
Bono, A; De Moura, JL; De Pauw, M; Denis, L; Keuppens, F; Mahler, C; Newling, DW; Robinson, M; Smith, PH; Sylvester, R1
Iversen, P1
Cariou, G; Coloby, P; Colombel, P; Coulange, C; Fourcade, RO; Grise, P; Mangin, P; Poterre, M; Soret, JY1
Boccardo, F; Cortellini, P; Decensi, A; Delli Ponti, U; Giuliani, L; Guarneri, D; Martorana, G; Oneto, F; Petracco, S; Rubagotti, A1
Elder, JS; Gibbons, RP1
Bono, A; Carvalho, AP; de Moura, JL; De Pauw, M; Denis, L; Newling, D; Ongena, P; Smith, P; Sylvester, R1
Waxman, J1
Ceda, GP; Ceresini, G; Cortellini, P; Denti, L; Hoffman, AR; Valenti, G1
Abel, P; Cox, J; Farah, N; Fleming, J; Hewitt, G; O'Donoghue, EP; Sandow, J; Sikora, K; Waxman, J; Williams, G1
Aaronson, N; Da Silva, FC1
Kaldenhoff, H; Schulze, H; Senge, T1
Bouffioux, C1
Alioth, H; Müller, J; Senn, E1
Belanger, A; Borsanyi, JP; Dupont, A; Emond, J; Giguere, M; Labrie, F; Lacourciere, Y; Monfette, G1
Bandhauer, K; Hadziselimović, F; Senn, E1
Lynch, JH; O'Brien, WM1
Doberauer, C; Niederle, N; Schmidt, CG1
Belanger, A; Dupont, A; Giguere, M; Labrie, F; Lachance, R1
Soloway, MS1
Castagnetti, G; Dotti, A; Ferrari, G; Ferrari, P; Pollastri, CA; Tavoni, F1
Gold, E; Goulding, A1
Brun, E; Caputo, M; Castello, R; Furlani, L; Magnani, CM; Moghetti, P; Muggeo, M; Negri, C; Tosi, F1
de Voogt, H; Denis, L; Sylvester, RJ1
Belanger, A; Chertin, B; Farkas, A; Fridmans, A; Hartman, H; Labrie, F; Spitz, IM1
Brower, V1
Duensing, S; Grüllich, C; Hadaschik, BA; Höfner, T; Hohenfellner, M; Jäger, D; Pahernik, S; Vallet, S1

Reviews

1 review(s) available for flutamide and buserelin

ArticleYear
[LHRH agonists combined with antiandrogens in the treatment of metastasizing prostatic carcinoma].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1985, Nov-26, Volume: 74, Issue:48

    Topics: Androgen Antagonists; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Dogs; Drug Therapy, Combination; Flutamide; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Rats; Receptors, Cell Surface; Receptors, LHRH

1985

Trials

29 trial(s) available for flutamide and buserelin

ArticleYear
Total androgen ablation: European experience. The EORTC GU Group.
    The Urologic clinics of North America, 1991, Volume: 18, Issue:1

    Topics: Aged; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms

1991
Complete androgen deprivation prior to radical prostatectomy in patients with stage T3 cancer of the prostate.
    European urology, 1991, Volume: 19, Issue:3

    Topics: Aged; Buserelin; Combined Modality Therapy; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Pilot Projects; Preoperative Care; Prostatectomy; Prostatic Neoplasms; Time Factors

1991
A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    The Journal of urology, 1991, Volume: 146, Issue:5

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Drug Tolerance; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms; Remission Induction; Time Factors; United Kingdom

1991
Combined treatment (goserelin plus flutamide) versus monotherapy (goserelin alone) in advanced prostate cancer: a randomized study.
    Seminars in oncology, 1991, Volume: 18, Issue:5 Suppl 6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Carcinoma; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Remission Induction; Survival Rate

1991
Some limitations of the radioisotope bone scan in patients with metastatic prostatic cancer. A subanalysis of EORTC trial 30853. The EORTC Urological Group.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Radionuclide Imaging; Randomized Controlled Trials as Topic; Survival Rate

1990
Comparability of EORTC and DAPROCA studies in advanced prostatic cancer.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate

1990
Zoladex and flutamide versus bilateral orchiectomy. A randomized phase III EORTC 30853 study. The EORTC GU Group.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prognosis; Prostatic Neoplasms; Radionuclide Imaging; Randomized Controlled Trials as Topic; Survival Rate

1990
A phase III trial of zoladex and flutamide versus orchiectomy in the treatment of patients with advanced carcinoma of the prostate.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate

1990
Zoladex and flutamide versus orchiectomy in the treatment of advanced prostatic cancer. A combined analysis of two European studies, EORTC 30853 and DAPROCA 86.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate

1990
Complete androgen blockade: data from an EORTC 30853 trial.
    Seminars in urology, 1990, Volume: 8, Issue:3

    Topics: Aged; Anilides; Buserelin; Combined Modality Therapy; Europe; Flutamide; Goserelin; Humans; Male; Middle Aged; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Rate

1990
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
    European urology, 1990, Volume: 18, Issue:1

    Topics: Aged; Androgen Antagonists; Anilides; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation

1990
Phase II Radiation Therapy Oncology Group study of hormonal cytoreduction with flutamide and Zoladex in locally advanced carcinoma of the prostate treated with definitive radiotherapy.
    American journal of clinical oncology, 1990, Volume: 13, Issue:6

    Topics: Buserelin; Diarrhea; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms; Radiotherapy

1990
Orchidectomy versus Zoladex plus Eulexin in patients with metastatic prostate cancer (EORTC 30853).
    The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Combinations; Drug Evaluation; Europe; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Risk Factors

1990
[How can a nursing team participate in a clinical trial? Zoladex, flutamide trial].
    Soins; la revue de reference infirmiere, 1990, Issue:540

    Topics: Buserelin; Clinical Trials as Topic; Flutamide; Goserelin; Humans; Job Description; Male; Nursing Staff, Hospital; Prostatic Neoplasms

1990
A multicenter trial comparing the luteinizing hormone releasing hormone analog Zoladex, with Zoladex plus flutamide in the treatment of advanced prostate cancer. The International Prostate Cancer Study Group.
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Buserelin; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms

1990
Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Carcinoma; Combined Modality Therapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Liver Function Tests; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Survival Rate

1990
Zoladex plus flutamide vs. orchidectomy for advanced prostatic cancer. Danish Prostatic Cancer Group (DAPROCA).
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Combined Modality Therapy; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Orchiectomy; Prostatic Neoplasms; Survival Rate

1990
Total androgen blockade with Zoladex plus flutamide vs. Zoladex alone in advanced prostatic carcinoma: interim report of a multicenter, double-blind, placebo-controlled study.
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Double-Blind Method; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Survival Rate

1990
Zoladex with or without flutamide in the treatment of locally advanced or metastatic prostate cancer: interim analysis of an ongoing PONCAP study. Italian Prostatic Cancer Project (PONCAP).
    European urology, 1990, Volume: 18 Suppl 3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Flutamide; Follow-Up Studies; Goserelin; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Rate

1990
Zoladex and flutamide vs orchidectomy: a phase III EORTC 30853 trial. EORTC Urological Group.
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Anilides; Buserelin; Clinical Trials as Topic; Europe; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prognosis; Prospective Studies; Prostatic Neoplasms; Random Allocation

1989
'Zoladex' versus 'Zoladex' plus flutamide in the treatment of advanced prostate cancer. First interim analysis of an international trial. International Prostate Cancer Study Group.
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Aged; Anilides; Buserelin; Clinical Trials as Topic; Drug Therapy, Combination; Flutamide; Goserelin; Humans; International Cooperation; Male; Multicenter Studies as Topic; Prognosis; Prostatic Neoplasms; Random Allocation

1989
Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
    Progress in clinical and biological research, 1989, Volume: 303

    Topics: Aged; Aged, 80 and over; Androgen Antagonists; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation

1989
The clinical and endocrine assessment of three different antiandrogen regimens combined with a very long-acting gonadotrophin-releasing hormone analogue.
    American journal of clinical oncology, 1988, Volume: 11 Suppl 2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Flutamide; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Phosphoric Monoester Hydrolases; Prostatic Neoplasms; Random Allocation; Testosterone

1988
Quality of life assessment in prostatic cancer.
    Progress in clinical and biological research, 1988, Volume: 260

    Topics: Buserelin; Clinical Trials as Topic; Europe; Flutamide; Goserelin; Humans; Male; Orchiectomy; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires

1988
Evaluation of total versus partial androgen blockade in the treatment of advanced prostatic cancer.
    Urologia internationalis, 1988, Volume: 43, Issue:4

    Topics: Androgen Antagonists; Androgens; Buserelin; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation

1988
Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
    European urology, 1988, Volume: 15, Issue:3-4

    Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Time Factors

1988
Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.
    Journal of steroid biochemistry, 1986, Volume: 25, Issue:5B

    Topics: Androgen Antagonists; Antineoplastic Agents; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Diethylstilbestrol; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Neoplasm Staging; Orchiectomy; Prostatic Neoplasms; Triptorelin Pamoate

1986
Combination treatment in M1 prostate cancer.
    Cancer, 1993, Dec-15, Volume: 72, Issue:12 Suppl

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone

1993
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
    European urology, 1998, Volume: 33, Issue:2

    Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate

1998

Other Studies

23 other study(ies) available for flutamide and buserelin

ArticleYear
Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
    The Journal of urology, 1992, Volume: 148, Issue:6

    Topics: 5-alpha Reductase Inhibitors; Androstenes; Animals; Azasteroids; Buserelin; Clusterin; Finasteride; Flutamide; Glycoproteins; Male; Molecular Chaperones; Organ Size; Prostate; Random Allocation; Rats; Rats, Sprague-Dawley; Seminal Vesicles

1992
[A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
    Der Internist, 1992, Volume: 33, Issue:4

    Topics: Aged; Androgen Antagonists; Angina Pectoris; Buserelin; Calcitonin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Hyperhidrosis; Male; Prostatic Neoplasms

1992
Prostatic specific antigen and the prediction of prognosis in metastatic prostatic cancer.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Orchiectomy; Predictive Value of Tests; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Radionuclide Imaging; Survival Rate

1990
Lymphangitic carcinomas of the lung as presentation of prostatic cancer. A case report.
    Tumori, 1991, Feb-28, Volume: 77, Issue:1

    Topics: Buserelin; Carcinoma; Flutamide; Goserelin; Humans; Lung Neoplasms; Lymphangitis; Male; Middle Aged; Prostatic Neoplasms

1991
Proteins C and S in patients with advanced prostatic cancer.
    Thrombosis research, 1991, Jul-01, Volume: 63, Issue:1

    Topics: Buserelin; Carrier Proteins; Complement C4b; Complement Inactivator Proteins; Flutamide; Glycoproteins; Humans; Male; Orchiectomy; Prostatic Neoplasms; Protein C; Protein S

1991
Bone marrow regeneration after hormonal therapy in patients with bone metastases from prostate carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1991, Volume: 32, Issue:12

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Bone Marrow; Bone Neoplasms; Buserelin; Flutamide; Goserelin; Humans; Male; Middle Aged; Organotechnetium Compounds; Prostatic Neoplasms; Radionuclide Imaging; Regeneration

1991
Maximal androgen blockade in prostatic cancer.
    Scandinavian journal of urology and nephrology. Supplementum, 1991, Volume: 138

    Topics: Androgen Antagonists; Buserelin; Flutamide; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Orchiectomy; Prostatic Neoplasms

1991
Suppression of plasma androgens by the antiandrogen flutamide in prostatic cancer patients treated with Zoladex, a GnRH analogue.
    Clinical endocrinology, 1990, Volume: 32, Issue:3

    Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androgens; Androstenedione; Anilides; Antineoplastic Agents; Buserelin; Dehydroepiandrosterone; Depression, Chemical; Flutamide; Goserelin; Humans; Hydroxyprogesterones; Male; Orchiectomy; Prostatic Neoplasms; Testosterone

1990
EORTC protocol 30853: orchidectomy versus zoladex plus flutamide in the management of metastatic carcinoma of the prostate. Interim statistical analysis of the side effects of treatment.
    Cancer, 1990, Sep-01, Volume: 66, Issue:5 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms

1990
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
    The Journal of urology, 1990, Volume: 144, Issue:4

    Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors

1990
Advances in the treatment of metastatic prostatic cancer.
    The Western journal of medicine, 1985, Volume: 143, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Diethylstilbestrol; Flutamide; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Male; Neoplasm Metastasis; Orchiectomy; Palliative Care; Prostatic Neoplasms

1985
Androgens do not regulate the growth hormone response to GHRH in elderly men.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1989, Volume: 21, Issue:12

    Topics: Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Goserelin; Growth Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Prostatic Neoplasms; Testosterone

1989
LHRH analogues in combination with an anti-androgen in the treatment of advanced disease.
    Hormone research, 1989, Volume: 32 Suppl 1

    Topics: Androgen Antagonists; Buserelin; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Prostatic Neoplasms

1989
Effect of treatment with chronic gonadotropin releasing hormone agonist on human testis.
    The Journal of urology, 1987, Volume: 138, Issue:4 Pt 2

    Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Flutamide; Humans; Leydig Cells; Male; Sertoli Cells; Spermatogenesis; Spermatogonia; Spermatozoa; Testis

1987
Hydroxyproline as a marker for following patients with metastatic prostate cancer.
    The Journal of urology, 1988, Volume: 139, Issue:1

    Topics: Bone Neoplasms; Buserelin; Creatinine; Flutamide; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Leuprolide; Male; Prostatic Neoplasms

1988
Advanced male breast cancer treatment with the LH-RH analogue buserelin alone or in combination with the antiandrogen flutamide.
    Cancer, 1988, Aug-01, Volume: 62, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Estradiol; Flutamide; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Middle Aged; Testosterone

1988
Long term treatment with luteinising hormone releasing hormone agonists and maintenance of serum testosterone to castration concentrations.
    British medical journal (Clinical research ed.), 1985, Aug-10, Volume: 291, Issue:6492

    Topics: Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Radioimmunoassay; Testosterone; Time Factors; Triptorelin Pamoate

1985
Newer methods of hormonal therapy for prostate cancer.
    Urology, 1984, Volume: 24, Issue:5 Suppl

    Topics: Adenocarcinoma; Aminoglutethimide; Androgen Antagonists; Bone Neoplasms; Buserelin; Flutamide; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Megestrol; Megestrol Acetate; Pituitary Hormone-Releasing Hormones; Prostatic Neoplasms

1984
Flutamide-mediated androgen blockade evokes osteopenia in the female rat.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1993, Volume: 8, Issue:6

    Topics: Androgens; Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Buserelin; Female; Flutamide; Hydroxyproline; Organ Size; Rats; Rats, Wistar; Uterus

1993
The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women.
    The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:3

    Topics: Adult; Androgen Antagonists; Androgens; Buserelin; Female; Flutamide; Glucose Clamp Technique; Humans; Hyperandrogenism; Insulin; Insulin Resistance; Ovulation; Spironolactone

1996
Partial androgen suppression consequent to increased secretion of adrenal androgens in a patient with prostate cancer treated with long-acting GnRH agonists.
    Prostate cancer and prostatic diseases, 2009, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aged; Androgen Antagonists; Androgens; Anilides; Buserelin; Diarrhea; Flutamide; Gastrectomy; Glaucoma; Gonadotropin-Releasing Hormone; Hernia, Hiatal; Humans; Luteinizing Hormone; Male; Nitriles; Peptic Ulcer; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tosyl Compounds

2009
Watchful waiting beats androgen deprivation therapy in early prostate cancer.
    Journal of the National Cancer Institute, 2008, Nov-05, Volume: 100, Issue:21

    Topics: Aged; Androgen Antagonists; Animals; Antineoplastic Agents, Hormonal; Buserelin; Drug Prescriptions; Flutamide; Humans; Imidazolidines; Leuprolide; Male; Patient Education as Topic; Patient Satisfaction; Prostatic Neoplasms; Retrospective Studies; Risk Assessment; Risk Factors; Survival Analysis

2008
Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.
    World journal of urology, 2015, Volume: 33, Issue:6

    Topics: Aged; Androgen Antagonists; Androstenes; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cohort Studies; Disease-Free Survival; Docetaxel; Flutamide; Humans; Leuprolide; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nitriles; Prostatic Neoplasms, Castration-Resistant; Retrospective Studies; Taxoids; Tosyl Compounds; Treatment Outcome; Triptorelin Pamoate

2015